Glucocorticoids Augment Fibroblast‐Mediated Contraction of Collagen Gels by Inhibition of Endogenous PGE Production
- 9 May 1999
- journal article
- Published by Wiley in Proceedings of the Association of American Physicians
- Vol. 111 (3) , 249-258
- https://doi.org/10.1046/j.1525-1381.1999.99269.x
Abstract
Glucocorticoids are currently regarded as the drug of choice in the treatment of inflammatory airway and lung diseases, however, they are not routinely effective in fibrotic phases of inflammation. In the current study, glucocorticoids were investigated for their ability to affect fibroblast mediated contraction of a three dimensional collagen gel, a measure of one aspect of tissue remodeling. Dexamethasone, budesonide, hydrocortisone and fluticasone propionate were all able to significantly augment fibroblast contractility in a concentration dependent manner. Glucocorticoids also had an augmentative effect on collagen gel contraction mediated by fibroblasts from bronchi, skin and bone marrow. The increased contractility was not due to cell proliferation or to collagen degradation, since the glucocorticoids did not alter the amounts of DNA and hydroxyproline in the gels. The concentration of prostaglandin E2 (PGE2) in supernatant media was lower from glucocorticoid-treated gels compared to control gels. Consistent with this, addition of exogenous PGE2 to the culture system restored the contractile properties and indomethacin augmented contraction similar to the glucocorticoids suggesting that inhibition of prostaglandins or related eicosanoids may be the mechanism by which the increased contractility occurs. DBcAMP, forskolin and the long lasting beta2-agonist formoterol were able to reverse the effect of the glucocorticoids on fibroblast mediated collagen gel contraction suggesting that enhancers of cAMP can counteract the effect of glucocorticoids. Thus, we provide evidence that glucocorticoids have the ability to directly augment fibroblast contractility by inhibiting fibroblast endogenous PGE synthesis. The findings could be one possible mechanism to explain the poor therapeutic response to glucocorticoids on the later stages of fibrotic diseases.Keywords
This publication has 33 references indexed in Scilit:
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Fibroblast contraction occurs on release of tension in attached collagen lattices: Dependency on an organized actin cytoskeleton and serumThe Anatomical Record, 1992
- Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U‐937 cellsFEBS Letters, 1991
- Cytokine-and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasoneBiochemical and Biophysical Research Communications, 1991
- Collagen lattice effects on fibroblast arachidonic acid metabolismJournal of Cellular Physiology, 1989
- Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.Journal of Clinical Investigation, 1986
- The Contractility of Fibroblasts in a Collagen Lattice Is Reduced by CorticosteroidsJournal of Investigative Dermatology, 1984
- Fibroblast contraction of collagen lattices in vitro: Inhibition by chronic inflammatory cell mediatorsJournal of Cellular Physiology, 1983
- Glucocorticoids and Collagen Synthesis: Comparison of in vivo and Cell Culture StudiesCollagen and Related Research, 1981